1. Home
  2. SABS vs QMMM Comparison

SABS vs QMMM Comparison

Compare SABS & QMMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • QMMM
  • Stock Information
  • Founded
  • SABS 2014
  • QMMM 2005
  • Country
  • SABS United States
  • QMMM Hong Kong
  • Employees
  • SABS N/A
  • QMMM N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • QMMM
  • Sector
  • SABS Health Care
  • QMMM
  • Exchange
  • SABS Nasdaq
  • QMMM NYSE
  • Market Cap
  • SABS 11.4M
  • QMMM 13.4M
  • IPO Year
  • SABS N/A
  • QMMM 2024
  • Fundamental
  • Price
  • SABS $1.37
  • QMMM $0.72
  • Analyst Decision
  • SABS Strong Buy
  • QMMM
  • Analyst Count
  • SABS 5
  • QMMM 0
  • Target Price
  • SABS $11.40
  • QMMM N/A
  • AVG Volume (30 Days)
  • SABS 25.6K
  • QMMM 240.7K
  • Earning Date
  • SABS 05-19-2025
  • QMMM 04-29-2025
  • Dividend Yield
  • SABS N/A
  • QMMM N/A
  • EPS Growth
  • SABS N/A
  • QMMM N/A
  • EPS
  • SABS N/A
  • QMMM N/A
  • Revenue
  • SABS $1,322,410.00
  • QMMM $2,698,229.00
  • Revenue This Year
  • SABS N/A
  • QMMM N/A
  • Revenue Next Year
  • SABS $50.00
  • QMMM N/A
  • P/E Ratio
  • SABS N/A
  • QMMM N/A
  • Revenue Growth
  • SABS N/A
  • QMMM N/A
  • 52 Week Low
  • SABS $1.00
  • QMMM $0.54
  • 52 Week High
  • SABS $5.01
  • QMMM $13.00
  • Technical
  • Relative Strength Index (RSI)
  • SABS 46.90
  • QMMM N/A
  • Support Level
  • SABS $1.30
  • QMMM N/A
  • Resistance Level
  • SABS $1.49
  • QMMM N/A
  • Average True Range (ATR)
  • SABS 0.13
  • QMMM 0.00
  • MACD
  • SABS 0.04
  • QMMM 0.00
  • Stochastic Oscillator
  • SABS 75.51
  • QMMM 0.00

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About QMMM QMMM HOLDINGS LIMITED

QMMM Holdings Ltd is a digital advertising and marketing production services company. It operates through its two wholly owned subsidiaries: ManyMany Creations and Quantum Matrix. It has used interactive design, animation, art-tech and virtual technologies in over 500 commercial campaigns. The company has worked with large domestic and international banks, real estate developers, amusement parks, top international athletic apparel and footwear brands, and luxury cosmetic products and international brands for their advertising and creation work in Hong Kong. Its clients include local and international banks, real-estate developers, luxury brands, high fashion houses, and theme parks.

Share on Social Networks: